It’s thought around half of the world’s population are infected with H pylori.
Articles on Cancer
Displaying 1 - 20 of 1112 articles
Childhood cancer affects different tissues and has different causes. We need to treat it as a separate disease.
The devices make tumour-on-a-chip technology easier and cheaper to build, with the hope they can be moved into clinical use for personalized cancer treatment.
Ovarian cancer has a particularly poor survival rate. Only one in two women will live five years beyond their diagnosis.
Monoclonal antibody drugs like Keytruda attack cancer cells in a different way to chemotherapy drugs.
Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these tumors so deadly.
New research puts cosmic radiation exposure, not nuclear work, at the top of the list for radiation-related cancer deaths.
Researchers found that tumours on different catfish were genetically similar, indicating the fish were catching the cancer from each other.
Britain’s postwar sugar rationing was an accidental experiment. Decades on, it’s revealing how early diet shapes cancer risk, ageing and eating habits for life.
A viral post by a cancer specialist concedes there is no evidence of thyroid harm, while invoking hormone disruption and lifelong exposure. What does research show?
Three economists explore the viability of a UN-backed one-stop licensing ‘hub’ for making essential, often life-saving biotherapeutics and vaccines both affordable and more widely available.
Menopausal hormone therapy no longer has the highest-level warning label about the risk of breast cancer, opening a gray area on who would benefit most from treatment.
Four different animals are now known to spread cancer between individuals. Here’s why humans aren’t one of them.
Cancer survivors often experience cognitive, visual or physical challenges that hinder software use. Better designs can help.
Researchers are working to engineer bacteria that can kill cancerous tumours while reducing harm to healthy cells and tissue.
Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.
Dementia is now the leading cause of death, overtaking heart disease. The Conversation’s experts explain how Australians’ health has changed – both good and bad.
Science works at a much slower pace than social media, opening a large window for early findings to be taken at face value and misinformation to spread.
Knowing which cancer tumours have their own microbiomes could lead to more personalised treatments.
An oncologist answers the key questions about the new sitting-and-cancer study, and what its findings do and don’t show.
Top contributors
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Professor, Department of Biomedical and Life Sciences, Lancaster University
-
Senior Lecturer in Genetics and Molecular Biology, Kingston University
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Lecturer in Cancer Biology & Clinical Biochemistry, Kingston University
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Professor, School of Medicine, University of Connecticut
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Associate professor, University of Sydney
-
Graduate Student in Cancer Systems Biology, Rice University
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Professor, Paediatrics and Child Health, UNSW